Webamazon kicked off june with an announcement that it would stop testing for cannabis metabolites as part of its drug screening program for positions not regulated.
Webamazon kicked off june with an announcement that it would stop testing for cannabis metabolites as part of its drug screening program for positions not regulated.
Webin a june blog post, amazon said it “will no longer include marijuana in our comprehensive drug screening program” for jobs that are not regulated by the u. s.